2-(2-Aminophenoxy)-1-(morpholin-4-yl)ethan-1-one | 926272-98-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 2-(2-Aminophenoxy)-1-(morpholin-4-yl)ethan-1-one
• 英文别名: 2-(2-aminophenoxy)-1-morpholin-4-ylethanone
• CAS: 926272-98-2
• 化学式: C₁₂H₁₆N₂O₃
• mdl: MFCD09047579
• 分子量: 236.27
• InChiKey: YTTICQQKMRYDDW-UHFFFAOYSA-N

物化性质

• 沸点：
  466.3±45.0 °C(Predicted)
• 密度：
  1.240±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.1
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.416
• 拓扑面积：
  64.8
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• [EN] GLYCINE B ANTAGONISTS<br/>[FR] ANTAGONISTES DE LA GLYCINE B
  申请人：MERZ PHARMA GMBH & CO KGAA

  公开号：WO2010139481A1

  公开（公告）日：2010-12-09

  The invention relates to naphthalene derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are glycine B antagonists and are therefore useful for the control and prevention of various disorders, including neurological disorders.

  该发明涉及萘衍生物以及它们的药用可接受盐。该发明还涉及一种制备这些化合物的方法。该发明的化合物是甘氨酸B拮抗剂，因此对于控制和预防各种疾病，包括神经系统疾病，具有用处。
• Metal biosensors based on compounds with metal-sensitive chemical shifts for magnetic resonance spectroscopy and imaging
  申请人：Klinikum rechts der Isar der Technischen Universität München

  公开号：EP3015855A1

  公开（公告）日：2016-05-04

  The present invention relates to the use of compounds with at least one metal-sensitive chemical shift for determining metal concentrations and/or measuring metal concentration changes, wherein the compound is selected from the group of: pyro-EGTA, EGTA, EDTA, AATA, APTRA, BAPTA, HIDA, citrate, CarboxyGlutamate (CGlu), arylazo chromotopic acid, beta-diketone (crown-ether), mono-, di-, or tri-pyridyl aniline, mono-, di-, or tri-pyridyl amine, trimethylphenylammonium, or derivatives thereof. The present invention further relates to biosensors comprising at least one of the compounds. The present invention also relates to the use of the compounds for diagnosing and/or monitoring treatment of a disease causing changes in metal concentrations. The present invention is furthermore related to in vitro and in vivo methods for determining metal concentration and/or measuring metal concentration changes using the compounds or biosensors. The present invention also relates to methods of diagnosing and/or monitoring treatment of a disease causing changes in metal concentrations wherein the compounds or biosensors are applied. The present invention also relates to use of the compounds or biosensors in quality control of food or in the examination of plants and organisms or for monitoring of environmental resources. The present invention further relates to novel derivatives of pyro-EGTA, AATA, APTRA and BAPTA as well as their uses.

  本发明涉及具有至少一种金属敏感化学位移的化合物用于确定金属浓度和/或测量金属浓度变化的用途，其中化合物选自以下组别：pyro-EGTA、EGTA、EDTA、AATA、APTRA、BAPTA、HIDA、柠檬酸盐、羧基谷氨酸（CGlu）、芳基偶氮发色酸、β-二酮（冠醚）、单吡啶基、二吡啶基或三吡啶基苯胺、单吡啶基、二吡啶基或三吡啶基胺、三甲基苯基铵或其衍生物。本发明还涉及包含至少一种上述化合物的生物传感器。本发明还涉及使用这些化合物诊断和/或监测引起金属浓度变化的疾病的治疗。本发明还涉及使用化合物或生物传感器确定金属浓度和/或测量金属浓度变化的体外和体内方法。本发明还涉及应用化合物或生物传感器诊断和/或监测引起金属浓度变化的疾病的治疗方法。本发明还涉及化合物或生物传感器在食品质量控制、植物和生物体检查或环境资源监测中的用途。本发明还涉及吡咯-EGTA、AATA、APTRA 和 BAPTA 的新型衍生物及其用途。
• [EN] METAL BIOSENSORS BASED ON COMPOUNDS WITH METAL-SENSITIVE CHEMICAL SHIFTS FOR MAGNETIC RESONANCE SPECTROSCOPY AND IMAGING AND THEIR USES<br/>[FR] BIOCAPTEURS DE MÉTAL BASÉS SUR DES COMPOSÉS PRÉSENTANT DES DÉPLACEMENTS CHIMIQUES SENSIBLES AUX MÉTAUX POUR SPECTROMÉTRIE ET IMAGERIE PAR RÉSONANCE MAGNÉTIQUE ET LEURS UTILISATIONS
  申请人：KLINIKUM RECHTS DER ISAR DER TECH UNIVERSITÄT MÜNCHEN

  公开号：WO2016066638A1

  公开（公告）日：2016-05-06

  The present invention relates to the use of compounds with at least one metal-sensitive chemical shift for determining metal concentrations and/or measuring metal concentration changes, by quantifying the NMR signal corresponding to said metal-specific chemical shift, preferably its intensity, frequency and/or bandwidth, wherein the compound is selected from the group of pyro-EGTA, EGTA, EDTA, AATA, APTRA, BAPTA, HIDA, citrate, CarboxyGlutamate (CGlu), arylazo chromotopic acid, beta-diketone (crown-ether), mono-, di-, or tri-pyridyl aniline, mono-, di-, or tri-pyridyl amine, trimethylphenylammonium, or derivatives thereof. The present invention also relates to methods of diagnosing and/or monitoring treatment of a disease causing changes in metal concentrations.